DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Nihonbashi Life Science HUB

2018 年 10 月 25 日 9:00 上午 - 2018 年 10 月 26 日 6:00 下午

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

[Session 2] Non Clinical Proarrhythmic Risk Assessment

Session Chair(s)

Katsuyoshi  Chiba, PhD

Katsuyoshi Chiba, PhD

Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D

Daiichi Sankyo Co., Ltd., Japan

Yasunari  Kanda, PhD

Yasunari Kanda, PhD

Head of Division of Pharmacology

National Institute of Health Sciences, Japan

Speaker(s)

Atsushi  Sugiyama, MD, PhD

Keynote Lecture: Prediction and Quantification of Torsadogenic Potential Using Classical and New Assay Models

Atsushi Sugiyama, MD, PhD

Toho University Faculty of Medicine, Japan

Professor and Chairman, Department of Pharmacology

Gary  Gintant, PhD

CiPA: Validation Efforts and Update

Gary Gintant, PhD

AbbVie Inc., United States

Research Fellow

Yasunari  Kanda, PhD

JiCSA Update: Proarrhythmia Risk Assessment Using Human iPS Cell-derived Cardiomyocytes

Yasunari Kanda, PhD

National Institute of Health Sciences, Japan

Head of Division of Pharmacology

Keiichi  Asakura, PhD

iSmart (investigation of in silico / in vitro model for Arrhythmogenic Risk Prediction) Update

Keiichi Asakura, PhD

Nippon Shinyaku Co., Ltd., Japan

Senior Scientist, Pharmacokinetics and Safety Assessment Department

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。